drugset / Trial / NCT01561066
Autologous Fibrin Glues for Fistulas Closure
Non-randomizedParallel-groupOpen-labelTreatment
Summary
Adjuvant use of fibrin glue in the fistula tract may promote healing in low-output enterocutaneous fistulas. However, there are only few studies that report autologous glue application in a larger patient group or clinical-controlled studies in this setting. The aim of this study was to investigate the efficacy and safety of autologous platelet-rich fibrin glue (PRFG) in the treatment of low-output digestive fistulas and compare them with conservative management without the use of adjuvant application of FG into the fistulous tract.
Timeline
- Start
- 2008-01
- Primary completion
- 2012-01
- Completion
- 2012-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Octreotide | Peptide | 0.3 mg | Subcutaneous |